These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire? Zinzani PL; Tani M; Alinari L; Stefoni V; Baccarani M Leuk Res; 2003 May; 27(5):465-6. PubMed ID: 12620298 [No Abstract] [Full Text] [Related]
26. [Therapy of Waldenström´s macroglobulinaemia in the year 2014]. Adam Z; Krejčí M; Pour L; Ševčíková E Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419 [TBL] [Abstract][Full Text] [Related]
36. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? Clavio M; Quintino S; Venturino C; Ballerini F; Varaldo R; Gatto S; Galbusera V; Garrone A; Grasso R; Canepa L; Miglino M; Pierri I; Gobbi M J Exp Clin Cancer Res; 2001 Sep; 20(3):351-8. PubMed ID: 11718214 [TBL] [Abstract][Full Text] [Related]
37. Alkylating agents for Waldenstrom's macroglobulinaemia. Yang K; Tan J; Wu T Cochrane Database Syst Rev; 2009 Jan; (1):CD006719. PubMed ID: 19160296 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia. Kim HD; Shin KC; Cho HS; Kim MK; Lee KH; Hyun MS J Korean Med Sci; 2007 Dec; 22(6):1079-81. PubMed ID: 18162727 [TBL] [Abstract][Full Text] [Related]